Recombinant full-length Plasmodium falciparum circumsporozoite protein-based vaccine adjuvanted with GLA-LSQ: Results of Phase 1 testing with malaria challenge.
Friedman-Klabanoff DJ, Berry AA, Travassos MA, Shriver M, Cox C, Butts J, Lundeen JS, Strauss KA, Joshi S, Shrestha B, Mo AX, Nomicos EYH, Deye GA, Regules JA, Bergmann-Leitner ES, Pasetti MF, Laurens MB.
Friedman-Klabanoff DJ, et al. Among authors: butts j.
J Infect Dis. 2024 Feb 8:jiae062. doi: 10.1093/infdis/jiae062. Online ahead of print.
J Infect Dis. 2024.
PMID: 38330357